Biblio

Export 3288 results:
Author Title Type [ Year(Asc)]
Filters: Filter is   [Clear All Filters]
2017
Y. Shi, Gu, L., Alsharif, A. Azeez, and Zhang, Z., “The Distinction of Amyloid-β Protein Precursor (AβPP) Ratio in Platelet Between Alzheimer's Disease Patients and Controls: A Systematic Review and Meta-Analysis.”, J Alzheimers Dis, vol. 59, no. 3, pp. 1037-1044, 2017.
V. Chandra and Mehta, V. Singh, “Distribution of Types of Dementia in the First 100 Patients Seen at a Dementia Clinic in India.”, J Alzheimers Dis, vol. 59, no. 3, pp. 797-801, 2017.
J. Andreotti, Dierks, T., Wahlund, L. - O., and Grieder, M., “Diverging Progression of Network Disruption and Atrophy in Alzheimer's Disease and Semantic Dementia.”, J Alzheimers Dis, vol. 55, no. 3, pp. 981-993, 2017.
B. Xie, Liu, Z., Liu, W., Jiang, L., Zhang, R., Cui, D., Zhang, Q., and Xu, S., “DNA Methylation and Tag SNPs of the BDNF Gene in Conversion of Amnestic Mild Cognitive Impairment into Alzheimer's Disease: A Cross-Sectional Cohort Study.”, J Alzheimers Dis, vol. 58, no. 1, pp. 263-274, 2017.
F. Monacelli, Cea, M., Borghi, R., Odetti, P., and Nencioni, A., “Do Cancer Drugs Counteract Neurodegeneration? Repurposing for Alzheimer's Disease.”, J Alzheimers Dis, vol. 55, no. 4, pp. 1295-1306, 2017.
A. Adrait, Perrot, X., Nguyen, M. - F., Gueugnon, M., Petitot, C., Collet, L., Roux, A., and Bonnefoy, M., “Do Hearing Aids Influence Behavioral and Psychological Symptoms of Dementia and Quality of Life in Hearing Impaired Alzheimer's Disease Patients and Their Caregivers?”, J Alzheimers Dis, vol. 58, no. 1, pp. 109-121, 2017.
S. Ochmann, Dyrba, M., Grothe, M. J., Kasper, E., Webel, S., Hauenstein, K., and Teipel, S. J., “Does Functional Connectivity Provide a Marker for Cognitive Rehabilitation Effects in Alzheimer's Disease? An Interventional Study.”, J Alzheimers Dis, vol. 57, no. 4, pp. 1303-1313, 2017.
E. E. Sundermann, Biegon, A., Rubin, L. H., Lipton, R. B., Landau, S., and Maki, P. M., “Does the Female Advantage in Verbal Memory Contribute to Underestimating Alzheimer's Disease Pathology in Women versus Men?”, J Alzheimers Dis, vol. 56, no. 3, pp. 947-957, 2017.
E. Doran, Keator, D., Head, E., Phelan, M. J., Kim, R., Totoiu, M., Barrio, J. R., Small, G. W., Potkin, S. G., and Lott, I. T., “Down Syndrome, Partial Trisomy 21, and Absence of Alzheimer's Disease: The Role of APP.”, J Alzheimers Dis, vol. 56, no. 2, pp. 459-470, 2017.
G. Manassero, Guglielmotto, M., Monteleone, D., Vasciaveo, V., Butenko, O., Tamagno, E., Arancio, O., and Tabaton, M., “Dual Mechanism of Toxicity for Extracellular Injection of Tau Oligomers versus Monomers in Human Tau Mice.”, J Alzheimers Dis, vol. 59, no. 2, pp. 743-751, 2017.
J. Godin, Armstrong, J. J., Rockwood, K., and Andrew, M. K., “Dynamics of Frailty and Cognition After Age 50: Why It Matters that Cognitive Decline is Mostly Seen in Old Age.”, J Alzheimers Dis, vol. 58, no. 1, pp. 231-242, 2017.
S. Jiang and Bhaskar, K., “Dynamics of the Complement, Cytokine, and Chemokine Systems in the Regulation of Synaptic Function and Dysfunction Relevant to Alzheimer's Disease.”, J Alzheimers Dis, vol. 57, no. 4, pp. 1123-1135, 2017.
A. Tort-Merino, Valech, N., Peñaloza, C., Grönholm-Nyman, P., León, M., Olives, J., Estanga, A., Ecay-Torres, M., Fortea, J., Martínez-Lage, P., Molinuevo, J. L., Laine, M., Rodríguez-Fornells, A., and Rami, L., “Early Detection of Learning Difficulties when Confronted with Novel Information in Preclinical Alzheimer's Disease Stage 1.”, J Alzheimers Dis, vol. 58, no. 3, pp. 855-870, 2017.
C. M. Dengler-Crish, Smith, M. A., and Wilson, G. N., “Early Evidence of Low Bone Density and Decreased Serotonergic Synthesis in the Dorsal Raphe of a Tauopathy Model of Alzheimer's Disease.”, J Alzheimers Dis, vol. 55, no. 4, pp. 1605-1619, 2017.
J. Goossens, Laton, J., Van Schependom, J., Gielen, J., Struyfs, H., Van Mossevelde, S., Van den Bossche, T., Goeman, J., De Deyn, P. Paul, Sieben, A., Martin, J. - J., Van Broeckhoven, C., van der Zee, J., Engelborghs, S., and Nagels, G., “EEG Dominant Frequency Peak Differentiates Between Alzheimer's Disease and Frontotemporal Lobar Degeneration.”, J Alzheimers Dis, vol. 55, no. 1, pp. 53-58, 2017.
M. Balietti, Giuli, C., Fattoretti, P., Fabbietti, P., Papa, R., Postacchini, D., and Conti, F., “Effect of a Comprehensive Intervention on Plasma BDNF in Patients with Alzheimer's Disease.”, J Alzheimers Dis, vol. 57, no. 1, pp. 37-43, 2017.
Y. Ying Lim, Williamson, R., Laws, S. M., Villemagne, V. L., Bourgeat, P., Fowler, C., Rainey-Smith, S., Salvado, O., Martins, R. N., Rowe, C. C., Masters, C. L., and Maruff, P., “Effect of APOE Genotype on Amyloid Deposition, Brain Volume, and Memory in Cognitively Normal Older Individuals.”, J Alzheimers Dis, vol. 58, no. 4, pp. 1293-1302, 2017.
L. I. Sinclair and Love, S., “Effect of APOE Genotype on Synaptic Proteins in Earlier Adult Life.”, J Alzheimers Dis, vol. 59, no. 3, pp. 1123-1137, 2017.
J. Morris K, Uy, R. Adeline Z., Vidoni, E. D., Wilkins, H. M., Archer, A. E., Thyfault, J. P., Miles, J. M., and Burns, J. M., “Effect of APOE ε4 Genotype on Metabolic Biomarkers in Aging and Alzheimer's Disease.”, J Alzheimers Dis, vol. 58, no. 4, pp. 1129-1135, 2017.
L. Pantoni, Poggesi, A., Diciotti, S., Valenti, R., Orsolini, S., Rocca, E. Della, Inzitari, D., Mascalchi, M., and Salvadori, E., “Effect of Attention Training in Mild Cognitive Impairment Patients with Subcortical Vascular Changes: The RehAtt Study.”, J Alzheimers Dis, vol. 60, no. 2, pp. 615-624, 2017.
H. An, Choi, B., Park, K. - W., Kim, D. - H., Yang, D. - W., Hong, C. Hyung, Kim, S. Yoon, and Han, S. - H., “The Effect of Escitalopram on Mood and Cognition in Depressive Alzheimer's Disease Subjects.”, J Alzheimers Dis, vol. 55, no. 2, pp. 727-735, 2017.
J. Toombs, Foiani, M. S., Paterson, R. W., Heslegrave, A., Wray, S., Schott, J. M., Fox, N. C., Lunn, M. P., Blennow, K., and Zetterberg, H., “Effect of Spinal Manometers on Cerebrospinal Fluid Amyloid-β Concentration.”, J Alzheimers Dis, vol. 56, no. 3, pp. 885-891, 2017.
A. Carotenuto, Rea, R., Traini, E., Fasanaro, A. Maria, Ricci, G., Manzo, V., and Amenta, F., “The Effect of the Association between Donepezil and Choline Alphoscerate on Behavioral Disturbances in Alzheimer's Disease: Interim Results of the ASCOMALVA Trial.”, J Alzheimers Dis, vol. 56, no. 2, pp. 805-815, 2017.
Y. Tripodis, Alosco, M. L., Zirogiannis, N., Gavett, B. E., Chaisson, C., Martin, B., McClean, M. D., Mez, J., Kowall, N., and Stern, R. A., “The Effect of Traumatic Brain Injury History with Loss of Consciousness on Rate of Cognitive Decline Among Older Adults with Normal Cognition and Alzheimer's Disease Dementia.”, J Alzheimers Dis, vol. 59, no. 1, pp. 251-263, 2017.
A. Katrine Bergland, Dalen, I., Larsen, A. Inge, Aarsland, D., and Soennesyn, H., “Effect of Vascular Risk Factors on the Progression of Mild Alzheimer's Disease and Lewy Body Dementia.”, J Alzheimers Dis, vol. 56, no. 2, pp. 575-584, 2017.

Pages